Graham Capital Management, L.P. Scholar Rock Holding Corp Transaction History

Graham Capital Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$7.84 - $16.79 $95,185 - $203,847	12,141 Added 41.48%	41,410 $344,000
Q1 2024 May 15, 2024	BUY	$13.2 - $17.76 $386,350 - $519,817	29,269 New	29,269 $519,000
Q2 2023 Aug 14, 2023	BUY	$5.79 - $9.11 $62,103 - $97,713	10,726 New	10,726 $80,000
Q3 2022 Nov 14, 2022	SELL	$5.33 - $11.3 $464,482 - $984,738	-87,145 Reduced 50.22%	86,380 $598,000
Q2 2022 Aug 15, 2022	BUY	$4.66 - $13.96 $692,480 - $2.07 Million	148,601 Added 596.22%	173,525 $952,000
Q1 2022 May 16, 2022	BUY	$11.89 - $24.68 $296,346 - $615,124	24,924 New	24,924 $321,000

175

75.6M

585K

862K

Ticker SRRK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,640,600
Market Cap $2.17B
Description
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Graham Capital Management, L.P. with notifications on news.